This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents. Top assignee: Sunnybrook Health Sciences Centre. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations in Cellular Monitoring: The Work of Michael Kolios
Introduction
Michael Kolios is an accomplished inventor based in Ancaster, Canada. He has made significant contributions to the field of medical technology, particularly in the area of cellular monitoring. His innovative approach utilizes low-frequency ultrasound to detect cellular damage, which has important implications for medical diagnostics.
Latest Patents
Kolios holds a patent for a method titled "Methods of monitoring cellular death using low frequency ultrasound." This patent describes a technique for detecting cellular damage within a subject by transmitting low-frequency ultrasound (20 MHz or below) into a selected site that has been exposed to stress capable of causing cellular death. The method involves receiving backscattered ultrasound and comparing it to a control measurement. Changes in intensity or spectral slope of the backscattered ultrasound indicate cellular death or damage at the site.
Career Highlights
Michael Kolios is affiliated with Sunnybrook Health Sciences Centre, where he applies his expertise in ultrasound technology to advance medical research and patient care. His work has the potential to enhance the understanding of cellular responses to various stressors, paving the way for improved diagnostic techniques.
Collaborations
Kolios has collaborated with notable colleagues in his field, including Gregory J. Czarnota and Michael D. Sherar. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Kolios is a pioneering inventor whose work in low-frequency ultrasound technology is making strides in the monitoring of cellular health. His contributions are vital to the advancement of medical diagnostics and treatment methodologies.